Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant enterococcus faecium in vitro

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 2, 2010, Pages 676-679

  Rahbar, Mohammad ^a   Mehrgan, Hadi ^b   Hadji Nejad, Sanaz ^b  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; PERPHENAZINE; PHENOTHIAZINE DERIVATIVE; PROMETHAZINE; THIETHYLPERAZINE MALEATE; THIORIDAZINE; TRIFLUOPERAZINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; DRUG COMBINATION; DRUG EFFECTS; DRUG POTENTIATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANIMALIA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTHIAZINES; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 77954740520     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00558.x     Document Type: Article

References (23)

1. Kristiansen JE. Antimicrobial activity of non-antibiotics. Acta Path Microbiol Scand 1992 100 (Suppl. 7 19.
2. Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, Pacheco T et al. Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro. Int J Antimicrob Agents 2003 22 : 250 253.
3. Martins M, Bleiss W, Marko A, Ordway D, Viveiros M, Leandro C et al. Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study. In vivo 2004 18 : 787 794.
4. Rice LB. Antimicrobial resistance in Gram-positive bacteria. Am J Med 2006 119 : S11 9.
5. Hendricks O, Molnar A, Butterworth TS, Butaye P, Kolmos HJ, Christensen JB et al. In vitro Activity of Phenothiazine Derivatives in Enterococcus faecalis and Enterococcus faecium. Basic Clin Pharmacol Toxicol 2005 96 : 33 6.
6. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S17. CLSI Wayne
7. Pillai SK, Moellering RC, Eliopoulos GM. Antimicrobial combinations. In : Lorian V (ed Antibiotics in Laboratory Medicine, 5th edn.
8. American Society for Microbiology. Instruction for authors. Antimicrob Agents Chemother 1995 39 : i xiv.
9. Ang JY, Ezike E, Asmar BI. Antibacterial resistance. Indian J Ped 2004 71 : 229 239.
10. Basu LR, Mazumdar K, Dutta NK, Karak P, Dastidar SG. Antibacterial property of the antipyschotic agent prochlorperazine, and its synergism with methdilazine. Microbiol Res 2005 160 : 95 100.
11. Kristiansen JE, Mortensen I. Antibacterial effect of four phenothiazines. Pharmacol Toxicol 1987 60 : 100 103.
12. Kaatz GW, Mougdal VV, Seo SM, Kristiansen JE. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003 47 : 719 726.
13. -. J Bioenerg Biomembr 1995 27 : 127 136.
14. Moffart AC (ed Clarke's Isolation and Identification of Drugs, 2nd edn.
15. Gentry-Weeks CR, Karkhoff-Schweizer R, Pikis A, Estay M, Keith JM. Survival of Enterococcus faecalis in mouse peritoneal macrophages. Infect Immun 1999 67 : 2160 2165.
16. Ordway D, Viveiros M, Leandro C, Arroz MJ, Amaral L. Intracellular activity of clinical concentrations of phenothiazines including thioridazine against phagocytosed Staphylococcus aureus. Int J Antimicrob Agents 2002 20 : 34 43.
17. Mazumder R, Chaudhuri SR, Mazumdar A. Antimicrobial potentiality of a phenothiazine group of antipyschotic drug-prochlorperazine. Indian J Exp Biol 2002 40 : 828 830.
18. Saha V, Gupta S, Daum RS. Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci. Infect Agents Dis 1992 1 : 310 318.
19. Amaral L, Viveiros M, Kristiansen JE. Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries. Trop Med Int Health 2001 6 : 1016 1022.
20. Nishioka T, Ogawa W, Kuroda T, Katsu T, Tsuchiya T. Gene cloning and characterization of EfmA, a cultidrug efflux pump, from Enterococcus faecium. Biol Pharm Bull 2009 32 : 483 488.
21. Singh KV, Malathum K, Murray BE. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother 2001 45 : 263 266.
22. Hummel A, Holzapfel WH, Franz CM. Characterisation and transfer of antibiotic resistance genes from enterococci isolated from food. Syst Appl Microbiol 2007 30 : 1 7.
23. Oyamada Y, Ito H, Fujimoto K, Asada R, Niga T, Okamoto R et al. Combination of known and unknown mechanisms confers high-level resistance to fluoroquinolones in Enterococcus faecium. J Med Microbiol 2006 55 : 729 736.